Antithyroid Drugs
Top Cited Papers
- 3 March 2005
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (9) , 905-917
- https://doi.org/10.1056/nejmra042972
Abstract
Antithyroid drugs, which have been available for more than half a century, are important in the management of hyperthyroidism, particularly in patients with Graves' disease, who have a high response rate. Since the responses of patients vary and these agents have potentially serious side effects, a working knowledge of their complex pharmacology is required. This review article considers recent pharmacologic and clinical data related to the use of these compounds.Keywords
This publication has 124 references indexed in Scilit:
- Antithyroid Drug-Induced Agranulocytosis: Special Reference to Normal White Blood Cell Count AgranulocytosisThyroid®, 2004
- The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves' Hyperthyroidism: One-Year Follow-Up of a Prospective, Randomized StudyJournal of Clinical Endocrinology & Metabolism, 2001
- Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves' HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 1997
- Methimazole and Propylthiouracil Equally Cross the Perfused Human Term Placental LobuleJournal of Clinical Endocrinology & Metabolism, 1997
- Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' diseaseJournal of Clinical Endocrinology & Metabolism, 1996
- Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study GroupJournal of Clinical Endocrinology & Metabolism, 1996
- Short-term treatment of Graves' disease with methimazole in high versus low dosesJournal of Internal Medicine, 1995
- Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' diseaseClinical Endocrinology, 1992
- ANTITHYROID DRUGS IN THE TREATMENT OF HYPERTHYROIDISM OF Graves' DISEASE: LONG‐TERM FOLLOW‐UP OF 434 PATIENTSClinical Endocrinology, 1989
- Pharmacokinetic Properties and Bioavailability of MethimazoleClinical Pharmacokinetics, 1985